Company Filing History:
Years Active: 2022-2023
Title: Ivan Pogorelic: Innovator in Pharmaceutical Sciences
Introduction
Ivan Pogorelic is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative medicinal compounds. With a total of 2 patents to his name, Pogorelic's work is recognized for its potential impact on medical treatments.
Latest Patents
Pogorelic's latest patents include a crystalline form of N-butyldeoxygalactonojirimycin. This invention relates to a crystalline form of [(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)-piperidine-3,4,5-triol], processes for its preparation, pharmaceutical compositions containing this crystalline form, and its use as a medicament, especially as a glycolipid biosynthesis inhibitor. This innovative approach aims to enhance the efficacy of treatments in the pharmaceutical industry.
Career Highlights
Ivan Pogorelic is currently associated with Idorsia Pharmaceuticals Ltd., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to developing new therapeutic solutions that address unmet medical needs.
Collaborations
Pogorelic collaborates with esteemed colleagues, including Vitor Oliveira and Jean-Paul Roduit. These partnerships foster a dynamic environment for innovation and research, contributing to the advancement of pharmaceutical sciences.
Conclusion
Ivan Pogorelic stands out as a dedicated inventor in the pharmaceutical field, with a focus on developing innovative medicinal compounds. His contributions, particularly in the area of glycolipid biosynthesis inhibitors, highlight the importance of research and collaboration in advancing healthcare solutions.